Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Keratosis, Actinic 12Mycosis Fungoides 2Lymphoma, T-Cell, Cutaneous 2Squamous Intraepithelial Lesions 1Skin Neoplasms 1Parapsoriasis 1Non-Melanoma Skin Cancers 1Non-Melanoma Skin Cancer (NMSC) 1Keratosis, Seborrheic 1Dermatitis, Contact 1Carcinoma, Squamous Cell 1Carcinoma, Basal Cell 1Carcinoma 1

Interventions

Ultrasonography, Doppler 1Tomography, Optical Coherence 1Gels 13-ingenyl angelate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Keratosis, Seborrheic × Gels × Dermatologic × Clear all
NCT01214564 2011-01-25

Study to Evaluate the Safety and Efficacy of PEP005(Ingenol Mebutate) Gel, 0.05%, in Patients With Seborrhoeic Keratosis

Peplin

Phase 2 Completed
24 enrolled
Dermatologic

Keratosis, Seborrheic, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡